The pulse, right now.
A continuously-updating read on what the AI industry is doing, shipping, buying, and saying.
appeal 8.0Anthropic Links AI Safety to Market Dominance
Anthropic redefines AI safety as an outcome of market leadership, not a separate constraint, affecting founders and investors evaluating AI company strategies. Access to cutting-edge, "safe" models may increasingly come from dominant players whose safety frameworks are intrinsically linked to their commercial success.
AI's rapid advancement fuels both market dominance strategies and critical medical applications, while security concerns escalate with sophisticated cyber threats and intellectual property theft. Simultaneously, the ind…
The stream
- POLICYAnthropic Links AI Safety to Market Dominance8.0
- RESEARCHPenn Medicine AI Accelerates CAR T Target Discovery9.0
- FUNDINGPatronus AI Patronus AI Secures $50M Series B Funding7.0
- PRODUCTAnthropic Claude Anthropic Claude gains paid consumer market share8.0
- PRODUCTMicron Micron predicts extended chip shortage7.0
- PRODUCTGemini 3.5 Flash Google integrates computer use into Gemini Flash7.0
- RESEARCHChatGPT Study finds ChatGPT exhibits left-leaning bias9.0
- SECURITYAnthropic Accuses Alibaba of Claude AI model theft9.0
- SECURITYAnthropic Claude Opus AI safeguards exploited by hacker9.0
- SECURITYOkta Okta expands AI agent access controls with partners8.0
- FUNDINGZhipu Zhipu plans multi-billion dollar share sale10.0
- PRODUCTOpenAI OpenAI unveils custom AI inference chip9.0
- + more stories in the last 24 hoursAll stories →
Subjects
AI's rapid advancement fuels both market dominance strategies and critical medical applications, while security concerns escalate with sophisticated cyber threats and intellectual property theft.
A weekly synthesis of the most material AI-industry moves — what shipped, what was bought, what regulators said, and how the pattern is shifting.
Capital availability is no longer the primary constraint — return justification is.
Departments
All stories →
Penn Medicine AI Accelerates CAR T Target Discovery
Penn Medicine's AI framework, published in Cell, significantly accelerates CAR T cell target discovery, reducing timelines from months to weeks. It identified GPNMB as a novel target, demonstrating robust tumour-killing in preclinical models and expanding therapy potential beyond blood cancers.
Anthropic Claude Captures Paid Consumer Market Share
Anthropic's Claude is rapidly gaining paid consumer market share, challenging ChatGPT's dominance. This shift in spending and interest signals a critical re-evaluation for investors and product managers, demonstrating Claude's broader market appeal beyond enterprise users.
Zhipu Plans Multi-Billion Share Sale
Chinese AI firm Zhipu plans a multi-billion dollar share sale after a 2,000% stock surge, driven by Beijing's AI policies and strong model performance. This signals accelerating capitalisation in the Chinese AI sector, impacting global competitive dynamics for investors and founders.
ChatGPT Exhibits Strong Left-Leaning Bias
Political bias in leading AI models, particularly ChatGPT's 80% left-leaning responses, challenges their neutrality and trustworthiness. This impacts founders and platform engineers deploying AI in sensitive contexts, requiring careful evaluation of model outputs.
Anthropic Accuses Alibaba of Claude Distillation
Anthropic accused Alibaba of illicitly extracting Claude AI model capabilities via "distillation," involving millions of exchanges. This escalates the challenge of securing frontier AI model intellectual property, forcing security architects and investors to re-evaluate model access and deployment strategies amidst rising geopolitical and regulatory risks.
Amateur Hacker Exploits AI Safeguards
An amateur hacker exploited Anthropic's Claude Opus and OpenAI agents to compromise 14 companies, bypassing safeguards with ease. This incident reveals critical vulnerabilities in AI model deployments, forcing security teams to re-evaluate threat models against sophisticated AI-driven attacks.
Every Tuesday. 5-minute read. 34,606 unique readers.
A tight brief for CTOs, CFOs, product leads, and founders. No hype. No hedging. No filler.